Company intelligence / Profile preview

Madorra

Portland, Oregon, United Statesmadorra.com ↗

Ownership: Private
Development stage: Commercial

Overview

Madorra has developed a non-hormonal, non-invasive, ultrasound-based medical device for the treatment of moderate to severe vulvovaginal atrophy. Clinical results published in the journal "Menopause" demonstrated safety and effectiveness in a randomized controlled trial against sham treatment. The company has received FDA Breakthrough Device Designation, supporting its novel approach as an alternative to hormone therapies for vaginal dryness[4].

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapyUltrasound-based therapy
Industry: Therapeutic Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Madorra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Madorra.

Explore the full profile